SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-017171
Filing Date
2023-05-03
Accepted
2023-05-03 16:08:17
Documents
16
Period of Report
2023-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230501.htm   iXBRL 8-K 79424
2 EX-10.1 gls-ex10_1.htm EX-10 106861
3 EX-10.2 gls-ex10_2.htm EX-10 85343
4 EX-10.3 gls-ex10_3.htm EX-10 32406
5 EX-10.4 gls-ex10_4.htm EX-10 122124
  Complete submission text file 0000950170-23-017171.txt   587479

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230501_lab.xml EX-101.LAB 13904
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230501.xsd EX-101.SCH 2460
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230501_pre.xml EX-101.PRE 10225
10 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230501_htm.xml XML 4881
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23883748
SIC: 2834 Pharmaceutical Preparations